Abstract
Serum total and low density lipoprotein (LDL) cholesterol are well known risk factors for coronary heart disease (CHD) [1–5], while HDL cholesterol has been shown to be associated with reduced risk, at least in some studies [6–9]. Many reports have demonstrated also a negative correlation between HDL and manifestations of cerebrovascular [10, 11] and peripheral vascular [12, 13] disease. Because age seems to greatly influence the concentration of plasma cholesterol and its fractions, it is important to delineate the trends of these parameters in the elderly and their prognostic significance. In western industrialized countries plasma total and LDL cholesterol progressively increase with age in both sexes, from youth through young adulthood into middle age [14], but few studies have reported these trends on persons aged sixties and above.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kannel WB, Castelli WP, McNamara PM (1967) The Coronary Profile: 12-year followup in the Framingham Study J Occup Med 9: 611–619
Slack J (1969) Risk of ischemic Heart Disease in familial Hyperlipoproteinemia Lancet ii: 1380–1382
Fredrickson DS, Goldstein JL, Brown MS (1977) The Familial hyperlipoproteinemias. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The Metabolic Basis of inherited disease. New York: McGraw Hill, 604–686
WHO Expert Committee on the Prevention of Coronary Heart Disease (1982) Prevention of Coronary Heart Disease, WHO Technical Report series No 678, WHO, Geneva, Switzerland
Stamler J, Wentworth D, Neaton JD, for the MRFIT Research Group (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenes of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 236: 2823–2828
Lewis B (1983) The Lipoproteins: predictors, protectors and pathogens. Br Med J 287: 1161–1164
Assmann G, Lewis B, Mancini M, Paoletti R, Schettler G, Co-Chairmen and other members of the european Atherosclerosis Society Study Group (1987) Strategies for the Prevention of Coronary Heart Disease: A Policy Document of the European Atherosclerosis Society. Eur Heart J 8: 77–88
Castelli WP, Garrison RJ, Wilson PWF, Abbott RO, Kalousdian S, Kannel WB (1986) Incidence of coronary heart diesease and lipoprotein cholesterol levels — The Framingham Study. JAMA 236: 2835–2838
Popock JJ, Shaper AG, Phillips AN, Walker M, Whitehead TP (1986) HDL cholesterol is not a major risk factor for ischemic heart disease in British men. Br Med J 292: 515–519
Taggart J, Stout RW (1979) Reduced HDL in stroke — Relationship with elevated triglyceride and hypertension. Eur J Clin Invest 9: 219–223
Rossner S, Kjellin KG, Mettinger KL, Siden A, Soderstrom CE (1978) Normal serum cholesterol but low HDL-cholesterol concentration in patients with ischemic cerebrovascular disease. Lancet i: 577–578
Bradby GVA, Valente AJ, Walton KW (1978) Serum HDL in peripheral vascular disease. Lancet ii: 1271–1272
Kirstein P, Olsson A (1979) HDL cholesterol is low in young and increases with age in male claudicators. Atherosclerosis 33: 145–148
Lewis B, Sigurdson G, Chait A et al. (1978) Serum lipoproteins in four European Communities: a quantitative comparison. Eur J Clin Invest 8: 165–173
Laurenzi M, Mancini M (in press) Plasma lipids in elderly men and women. Eur Heart J
Mattila KS, Marniemi J, Maki J, Juva K (1986) Lipids, lipoproteins and apolipoproteins in the elderly. Scand J Clin Invest 46: 131–136
Nicholson J, Gartside PS, Siegel M, Spencer W, Steiner PM, Gluecks CJ (1979) Lipid and lipoprotein distributions in octa- and nonagenarians. Metabolism 28: 51–55
Schneider J (1984) Lipid and lipoprotein values in octa- and nonagenarians free from overt degenerative arterial disease. Clin Chim Acta 143: 1–5
Alvarez C, Orejas A, Gonzales S, Diaz R, Golomo LF (1984) Reference intervals from serum lipids, lipoproteins and apolipoproteins in the elderly. Clin Chem 30: 404–406
Huttunen JK, Lansimies E, Voutilainen E et al. (1979) Effect of moderate physical exercise on serum lipoproteins: a controlled clinical trial with special reference to serum high density lipoproteins. Circulation 60: 1220–1226
Abramson JH, Gofin R, Peritz E (1982) Risk markers for mortality among elderly men. A community study in Jerusalem. J Chron Dis 35: 565–572
Di Minno G, Silver MJ, Cerbone AM, Rainone A, Postiglione A, Mancini M (1986) Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia. Arteriosclerosis 6: 203–211
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mancini, M., Fischetti, A., Cicerano, U., Gallotta, G., Cortese, C., Postiglione, A. (1988). Plasma and High Density Lipoprotein (HDL) —Cholesterol in the Elderly. In: Mörl, H., Diehm, C., Heusel, G. (eds) 45 Jahre Herzinfarkt- und Fettstoffwechselforschung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73440-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-73440-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18945-9
Online ISBN: 978-3-642-73440-3
eBook Packages: Springer Book Archive